metabolic networks and pathways

Association of metabolomics with PD-1 inhibitor plus chemotherapy outcomes in patients with advanced non-small-cell lung cancer
Liang Zheng, Fang Hu, Lin Huang, Jun Lu, Xiaohua Yang, Jianlin Xu, Shuyuan Wang, Yinchen Shen, Runbo Zhong, Tianqing Chu, Wei Zhang, Ying Li, Xiaoxuan Zheng, Baohui Han, Hua Zhong, Wei Nie, Xueyan Zhang

Journal for ImmunoTherapy of Cancer Apr 2024, 12 (4) e008190; DOI: 10.1136/jitc-2023-008190
Targeting oxidative phosphorylation to increase the efficacy of immune-combination therapy in renal cell carcinoma
Jihua Tian, Jing Luo, Xing Zeng, Chunjin Ke, Yanan Wang, Zhenghao Liu, Le Li, Yangjun Zhang, Zhiquan Hu, Chunguang Yang

Journal for ImmunoTherapy of Cancer Feb 2024, 12 (2) e008226; DOI: 10.1136/jitc-2023-008226
Targeting the aryl hydrocarbon receptor (AhR) with BAY 2416964: a selective small molecule inhibitor for cancer immunotherapy
Christina Kober, Julian Roewe, Norbert Schmees, Lars Roese, Ulrike Roehn, Benjamin Bader, Detlef Stoeckigt, Florian Prinz, Mátyás Gorjánácz, Helge Gottfried Roider, Catherine Olesch, Gabriele Leder, Horst Irlbacher, Ralf Lesche, Julien Lefranc, Mine Oezcan-Wahlbrink, Ankita Sati Batra, Nirmeen Elmadany, Rafael Carretero, Katharina Sahm, Iris Oezen, Frederik Cichon, Daniel Baumann, Ahmed Sadik, Christiane A Opitz, Hilmar Weinmann, Ingo V Hartung, Bertolt Kreft, Rienk Offringa, Michael Platten, Ilona Gutcher

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (11) e007495; DOI: 10.1136/jitc-2023-007495
Label-free metabolic imaging for sensitive and robust monitoring of anti-CD47 immunotherapy response in triple-negative breast cancer
Minfeng Yang, Arpan Mahanty, Chunjing Jin, Alex Ngai Nick Wong, Jung Sun Yoo

Journal for ImmunoTherapy of Cancer Sep 2022, 10 (9) e005199; DOI: 10.1136/jitc-2022-005199
Ironing out exercise on immuno-oncological outcomes
Janjira Soh, Zi Xiang Lim, Elaine Hsuen Lim, Brian K Kennedy, Jorming Goh

Journal for ImmunoTherapy of Cancer Sep 2022, 10 (9) e002976; DOI: 10.1136/jitc-2021-002976
Fibrinogen-like protein 2 promotes tumor immune suppression by regulating cholesterol metabolism in myeloid-derived suppressor cells
Lei Wu, Xudong Liu, Juan Lei, Nan Zhang, Huakan Zhao, Jiangang Zhang, Huan Deng, Yongsheng Li

Journal for ImmunoTherapy of Cancer Dec 2023, 11 (12) e008081; DOI: 10.1136/jitc-2023-008081
FGF/FGFR genomic amplification as a predictive biomarker for immune checkpoint blockade resistance: a short report
Nicolas Roussot, Julie Lecuelle, Lorraine Dalens, Caroline Truntzer, Francois Ghiringhelli

Journal for ImmunoTherapy of Cancer Oct 2023, 11 (10) e007763; DOI: 10.1136/jitc-2023-007763
Defects in intratumoral arginine metabolism attenuate the replication and therapeutic efficacy of oncolytic myxoma virus
Parker Dryja, Heather D Curtsinger, Mee Y Bartee, Eric Bartee

Journal for ImmunoTherapy of Cancer Jun 2023, 11 (6) e006388; DOI: 10.1136/jitc-2022-006388
Inhibition of lactate transport by MCT-1 blockade improves chimeric antigen receptor T-cell therapy against B-cell malignancies
Ernesto Lopez, Rajesh Karattil, Francesco Nannini, Gordon Weng-Kit Cheung, Lilian Denzler, Felipe Galvez-Cancino, Sergio Quezada, Martin A Pule

Journal for ImmunoTherapy of Cancer Jun 2023, 11 (6) e006287; DOI: 10.1136/jitc-2022-006287
Chemical augmentation of mitochondrial electron transport chains tunes T cell activation threshold in tumors
Yosuke Dotsu, Daisuke Muraoka, Naohisa Ogo, Yudai Sonoda, Kiyoshi Yasui, Hiroyuki Yamaguchi, Hideo Yagita, Hiroshi Mukae, Akira Asai, Hiroaki Ikeda

Journal for ImmunoTherapy of Cancer Feb 2022, 10 (2) e003958; DOI: 10.1136/jitc-2021-003958

Main menu

metabolic networks and pathways

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

metabolic networks and pathways

Pages